The skin, in particular the epidermis, offers unique opportunities to
investigate the induction and control of cellular proliferation and ti
ssue homeostasis both under in vivo and in vitro conditions. Moreover,
it represents one of the most feasible model systems for experimental
cancer research. As the primary border of the body, the skin has impo
rtant protective and defensive functions. A general response to extern
al injury consists of a thickening of the epithelial layer (epidermal
hyperplasia) combined with an inflammatory reaction. This hyperplastic
transformation of the skin is a critical condition of skin tumor deve
lopment (i.e., conversion and promotion) and of the wound response. It
is believed to be due to a transformation of keratinocytes into an ac
tivated state characterized by an increased rate of proliferation and
the ability to release a series of growth factors and other cytokines
that coordinate the defense reaction (e.g., hyperproliferation, recrui
tment of leukocytes, activation of the immune system) along auto- and
paracrine feedback loops. The initial and probably later phases of thi
s response depend critically on a local release of eicosanoids such as
prostaglandins and lipoxygenase-generated factors. A unique reaction
seen upon phorbol ester treatment of mouse skin is a strong induction
of the enzyme 8-lipoxygenase, which might be involved in skin tumor de
velopment by catalyzing the generation of clastogenic metabolites thou
ght to play a role in the conversion stage. Hyperplasia may be conside
red to be the result of an imbalance between the rates of cell gain an
d cell loss. Therefore, hyperplastic transformation has to be distingu
ished from another response of skin to external stimuli where the home
ostatic equilibrium is maintained (i.e., no hyperplasia develops in sp
ite of strong hyperproliferation). This balanced hyperproliferation as
induced by mild stimuli (pressure, phorbol ester 4-O-methyl-TPA) is n
either accompanied by inflammatory reactions nor by the symptoms of ke
ratinocyte activation. It may simply be due to an increased rate of ce
ll-cycle traverse in the proliferative tissue compartment. In contrast
, the prostaglandin-dependent activation of keratinocytes leading to h
yperplastic transformation resembles in many aspects (such as, for ins
tance, the activation of cell -cycle-related genes) the G(o)-S transit
ion of cells in vitro. The control of proliferative homeostasis in nor
mal epidermis is an unresolved problem. It is not known whether the ra
te of cell proliferation adapts automatically to the rate of terminal
differentiation or whether this adaption is regulated by local factors
such as the elusive chalones or other inhibitory signals like transfo
rming growth factor beta. The same is true for stimulatory growth fact
ors such as epidermal growth factor and transform ing growth factor-al
pha whose function may be that of wound hormones rather than of homeos
tatic regulators of normal tissue regeneration.